Harald Lahm
-
- Growth Hormone and Insulin-like Growth Factors 28
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 11
- Immunology top 5%
- Molecular Biology top 5%
- Congenital heart defects research 15
- Pluripotent Stem Cells Research 11
- CRISPR and Genetic Engineering 10
- Metabolism, Diabetes, and Cancer 10
- Oncology top 5%
-
- Lipid metabolism and disorders 8
-
- Congenital Heart Disease Studies 7
- Co-authors
- Eckhard WolfAndreas HoeflichJürgen R. FischerMarlon R. SchneiderHelmut J. KolbBernard SordatMarkus KraneHans‐Joachim Gabius
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Harald Lahm
100 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 122
- Endocrinology, Diabetes and Metabolism 1.1k
- Cancer Research 709
- Immunology 894
- Molecular Biology 2.3k
- Oncology 839
Countries citing papers authored by Harald Lahm
This map shows the geographic impact of Harald Lahm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Lahm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Lahm more than expected).
Fields of papers citing papers by Harald Lahm
This network shows the impact of papers produced by Harald Lahm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Lahm. The network helps show where Harald Lahm may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harald Lahm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 1 | |
| 5 | 2018 | 1 | |
| 6 | 2017 | 198 | |
| 7 | 2017 | 5 | |
| 8 | 2015 | 1 | |
| 9 | 2014 | 8 | |
| 10 | 2012 | 3 | |
| 11 | 2011 | 16 | |
| 12 | 2008 | 42 | |
| 13 | 2006 | 13 | |
| 14 | 2004 | 13 | |
| 15 | 2003 | 4 | |
| 16 | 2003 | 11 | |
| 17 | 2002 | 160 | |
| 18 | Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. | 2002 | 164 |
| 19 | 2001 | 25 | |
| 20 | 1992 | 105 |
About Harald Lahm
Harald Lahm is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Oncology, having authored 106 papers that have together received 4.2k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (28 papers), Congenital heart defects research (15 papers), Pluripotent Stem Cells Research (11 papers), Cancer, Hypoxia, and Metabolism (11 papers), CRISPR and Genetic Engineering (10 papers), Metabolism, Diabetes, and Cancer (10 papers), Lipid metabolism and disorders (8 papers) and Congenital Heart Disease Studies (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Cancer Research (709 citations) and Immunology (894 citations). Harald Lahm has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Eckhard Wolf, Andreas Hoeflich, Jürgen R. Fischer, Marlon R. Schneider, Helmut J. Kolb, Bernard Sordat, Markus Krane, Hans‐Joachim Gabius, Herbert Kaltner and Martina Dreßen. Their work appears in journals such as Circulation, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.